# –ü–ª–∞–Ω
–í–ê–ñ–ù–û: –ö—É—Ä—Å–æ–≤–∞—è –Ω–∞ —Ñ–∞–∫—É–ª—å—Ç–µ—Ç–µ –±–∏–æ–∏–Ω—Ñ–æ—Ä–º–∞—Ç–∏–∫–∏


--- 1
RFantibody: https://www.nature.com/articles/s41586-025-09721-5
–ê–∫–∫—É—Ä–∞—Ç–Ω–æ –æ–±–æ–π—Ç–∏ –º–æ–º–µ–Ω—Ç –ø–æ—á–µ–º—É –º—ã –Ω–µ –∏—Å–ø–æ–ª—å–∑—É–µ–º —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—É—é –º–æ–¥–µ–ª—å (–≤–æ–æ–±—â–µ –Ω–∞—à –≥–ª–∞–≤–Ω—ã–π –∞—Ä–≥—É–º–µ–Ω—Ç –≤ —Ç–æ–º, —á—Ç–æ —Å–∏–∫–≤–µ–Ω—Å–æ–≤ –±–æ–ª—å—à–µ, –º–æ–∂–Ω–æ –µ—â–µ —Å–∫–∞–∑–∞—Ç—å —á—Ç–æ —Å–∏–∫–≤–µ–Ω—Å—ã implicitly –∫–æ–¥–∏—Ä—É—é—Ç —Å—Ç—Ä—É–∫—Ç—É—Ä—É, –Ω—É –∏ –µ—â–µ –º–æ–∂–Ω–æ –ø—Ä–æ –∫–æ–º–ø—å—é—Ç –∏ —Å–ª–æ–∂–Ω–æ—Å—Ç—å –æ–±—Ä–∞–±–æ—Ç–∫–∏ –¥–∞–Ω–Ω—ã—Ö —Å–∫–∞–∑–∞—Ç—å) 
–°–∫–∞–∑–∞—Ç—å, —á—Ç–æ –µ—Å—Ç—å –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω–æ–µ –∫–æ–ª-–≤–æ —Å–∏–∫–≤–µ–Ω—Å–Ω—ã—Ö –º–æ–¥–µ–ª–µ–π, –∫–æ—Ç–æ—Ä—ã–µ –±—ã–ª–∏ –±—ã –∑–∞—Ç–æ—á–µ–Ω—ã –Ω–∞ –≥–µ–Ω–µ—Ä–∞—Ü–∏—é / –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏—é / –∑–∞–ø–æ–ª–Ω–µ–Ω–∏–µ –ø—Ä–æ–ø—É—Å–∫–æ–≤ –∞–Ω—Ç–∏—Ç–µ–ª –ø—Ä–æ—Ç–∏–≤ –∞–Ω—Ç–∏–≥–µ–Ω–æ–≤. 
 
–ü–æ—Å–º–æ—Ç—Ä–µ—Ç—å –∫–∞–∫–∏–µ –ë–î –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ bool, –ø–æ–Ω—è—Ç—å –∫–∞–∫ –Ω–∞–∑–Ω–∞—á–∞–ª—Å—è —Ñ–ª–∞–≥ 0 –∏–ª–∏ 1. (–µ—Å–ª–∏ —á—Ç–æ  - –≤ –∏–∑–¥–µ—Ä–∂–∫–∏ —Ä–∞–±–æ—Ç—ã). –ü—Ä–æ—Å—Ç–æ —Å—Å—ã–ª–∫–∏ –Ω–∞ –≤—Å–µ bool –∑–∞–∫–∏–Ω—É—Ç—å –≤ —á–∞—Ç–≥–ø—Ç –∏ –ø–æ–ø—Ä–æ—Å–∏—Ç—å –≤—ã—Ç–∞—â–∏—Ç—å –ª–æ–≥–∏–∫—É –ø—Ä–∏—Å–≤–æ–µ–Ω–∏—è 0 –∏–ª–∏ 1




1. –ê–∫—Ç—É–∞–ª—å–Ω–æ—Å—Ç—å
–ú–æ–∂–Ω–æ —è–≤–Ω–æ —Å—Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∞—Ç—å research gap:
¬´–ü–æ—á–µ–º—É –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–∏–µ antibody-only –º–æ–¥–µ–ª–∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã¬ª
2. –ê–Ω—Ç–∏—Ç–µ–ª–æ-–∞–Ω—Ç–∏–≥–µ–Ω –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è –∫–∞–∫ –æ–±—ä–µ–∫—Ç –º–æ–¥–µ–ª–∏—Ä–æ–≤–∞–Ω–∏—è
  2.1 Developability
–ü–æ–º–∏–º–æ –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏ –¥–ª—è —Ç–æ–≥–æ, —á—Ç–æ–±—ã mAb —Å—Ç–∞–ª —Ö–æ—Ä–æ—à–∏–º –ª–µ–∫–∞—Ä—Å—Ç–≤–æ–º, –æ–Ω –¥–æ–ª–∂–µ–Ω –æ–±–ª–∞–¥–∞—Ç—å –µ—â–µ —Ä—è–¥–æ–º —Å–≤–æ–π—Å—Ç–≤
–≤—ã—Å–æ–∫–∞—è –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç—å –Ω–µ –≥–∞—Ä–∞–Ω—Ç–∏—Ä—É–µ—Ç:
—Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç—å,—ç–∫—Å–ø—Ä–µ—Å—Å–∏—é,–æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –∞–≥—Ä–µ–≥–∞—Ü–∏–∏,–ø—Ä–∏–≥–æ–¥–Ω–æ—Å—Ç—å –∫ —Ç–µ—Ä–∞–ø–∏–∏;
–ø–æ—ç—Ç–æ–º—É –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏—è –∞–Ω—Ç–∏—Ç–µ–ª ‚Äî –º–Ω–æ–≥–æ–∫—Ä–∏—Ç–µ—Ä–∏–∞–ª—å–Ω–∞—è –∑–∞–¥–∞—á–∞.
2) –ö–æ–º–ø–æ–Ω–µ–Ω—Ç—ã developability (–Ω–∞ —É—Ä–æ–≤–Ω–µ –ø–æ–Ω—è—Ç–∏–π)
–ù–µ —É—Ö–æ–¥—è –≤ —Ö–∏–º–∏—é, –Ω–æ –ø–µ—Ä–µ—á–∏—Å–ª–∏—Ç—å:
—Ñ–∏–∑–∏–∫–æ-—Ö–∏–º–∏—á–µ—Å–∫–∏–µ —Å–≤–æ–π—Å—Ç–≤–∞ (–∑–∞—Ä—è–¥, –≥–∏–¥—Ä–æ—Ñ–æ–±–Ω–æ—Å—Ç—å);
—Å—Ç—Ä—É–∫—Ç—É—Ä–Ω–∞—è —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç—å;
—Å–∫–ª–æ–Ω–Ω–æ—Å—Ç—å –∫ –∞–≥—Ä–µ–≥–∞—Ü–∏–∏;
–∏–º–º—É–Ω–æ–≥–µ–Ω–Ω–æ—Å—Ç—å (humanness).
–∏ –ø–æ–¥–≤–æ–¥–∏–º –∫ –≤—ã–±–æ—Ä—É –Ω–∞–º–∏ –º–æ–¥–µ–ª–∏ p-IgGen (–≤–æ–∑–º–æ–∂–Ω–æ –º—ã –ø–æ–ø—Ä–æ–±—É–µ–º –±–æ–ª—å—à–µ –º–æ–¥–µ–ª–µ–π —Ç—é–Ω–∏—Ç—å, –Ω–æ –ø–æ–∫–∞ —Ç–∞–∫) 


2.2 –†–æ–ª—å –∞–Ω—Ç–∏–≥–µ–Ω–∞ –≤ –º–æ–¥–µ–ª–∏—Ä–æ–≤–∞–Ω–∏–∏
–ò–¥–µ—è:
–º—É—Ç–∞—Ü–∏–∏, —É—Å–∏–ª–∏–≤–∞—é—â–∏–µ binding, –º–æ–≥—É—Ç:
—É–≤–µ–ª–∏—á–∏–≤–∞—Ç—å –≥–∏–¥—Ä–æ—Ñ–æ–±–Ω–æ—Å—Ç—å,
—Å–Ω–∏–∂–∞—Ç—å —Ä–∞—Å—Ç–≤–æ—Ä–∏–º–æ—Å—Ç—å,
—É—Ö—É–¥—à–∞—Ç—å —ç–∫—Å–ø—Ä–µ—Å—Å–∏—é;
–ø–æ—ç—Ç–æ–º—É –∫–æ–Ω—Ç–µ–∫—Å—Ç –∞–Ω—Ç–∏–≥–µ–Ω–∞ –≤–∞–∂–µ–Ω –¥–ª—è –ø–æ–∏—Å–∫–∞ ‚Äú–¥–æ–ø—É—Å—Ç–∏–º—ã—Ö‚Äù —Ä–µ—à–µ–Ω–∏–π, –∞ –Ω–µ –ø—Ä–æ—Å—Ç–æ –º–∞–∫—Å–∏–º—É–º–∞ –∞—Ñ—Ñ–∏–Ω–∏—Ç–µ—Ç–∞. –ø–æ—ç—Ç–æ–º—É –¥–∞–ª–µ–µ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç—Å—è antigen-aware –º–æ–¥–µ–ª–∏ –∏ –ø–æ–¥—Ö–æ–¥—ã –∫ –∏—Ö –æ–±—É—á–µ–Ω–∏—é



3. –î–∞–Ω–Ω—ã–µ
  3.1 –°—Ç—Ä—É–∫—Ç—É—Ä—ã vs —Å–∏–∫–≤–µ–Ω—Å—ã
–°–¥–µ–ª–∞—Ç—å –∞–∫—Ü–µ–Ω—Ç –Ω–∞ —Ç–æ–º, —á—Ç–æ —Å–∏–∫–≤–µ–Ω—Å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö –±–æ–ª—å—à–µ, —á–µ–º —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã—Ö (–∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω–æ —Å–∫–æ–ª—å–∫–æ), –Ω–æ —Ç–µ–º –Ω–µ –º–µ–Ω–µ–µ –Ω–µ –æ—á–µ–Ω—å –º–Ω–æ–≥–æ.
–°—Ä–∞–≤–Ω–∏—Ç—å –¥–≤–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏—è –∞–Ω—Ç–∏—Ç–µ–ª–æ‚Äì–∞–Ω—Ç–∏–≥–µ–Ω–Ω—ã—Ö –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–π –∫–∞–∫ –æ–±—ä–µ–∫—Ç–∞ –º–∞—à–∏–Ω–Ω–æ–≥–æ –æ–±—É—á–µ–Ω–∏—è –∏ –ø–æ–∫–∞–∑–∞—Ç—å, –ø–æ—á–µ–º—É –Ω–∞ –ø—Ä–∞–∫—Ç–∏–∫–µ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –º–µ—Ç–æ–¥–æ–≤ –≤—ã–Ω—É–∂–¥–µ–Ω–Ω–æ —Ä–∞–±–æ—Ç–∞—é—Ç —Å –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—è–º–∏, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ç–∏–≤–Ω–æ—Å—Ç—å —Å—Ç—Ä—É–∫—Ç—É—Ä.
https://chatgpt.com/share/69605787-3d80-8008-8f5b-c8f439859291
https://chatgpt.com/share/69605879-a3ec-8008-b23d-7906eedbfb2f ‚Äî —Ç—É—Ç —Å–æ —Å—Å—ã–ª–∫–∞–º–∏ —Å—Ä–∞–∑—É, –Ω–æ —Å–º—ã—Å–ª –Ω–µ –≤ —ç—Ç–æ–º, –Ω–∞–¥–æ —Å—Ä–∞–≤–Ω–∏—Ç—å –≥–¥–µ –ª—É—á—à–µ

3.1 –°—Ç—Ä—É–∫—Ç—É—Ä—ã vs —Å–∏–∫–≤–µ–Ω—Å—ã
–û—Å–Ω–æ–≤–Ω–∞—è –∏–¥–µ—è —Ä–∞–∑–¥–µ–ª–∞:
–û–±–æ—Å–Ω–æ–≤–∞—Ç—å –≤—ã–±–æ—Ä —Å–∏–∫–≤–µ–Ω—Å–Ω–æ–≥–æ –ø–æ–¥—Ö–æ–¥–∞ —á–µ—Ä–µ–∑ —Å—Ä–∞–≤–Ω–µ–Ω–∏–µ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ç–∏–≤–Ω–æ—Å—Ç–∏ –¥–≤—É—Ö —Ç–∏–ø–æ–≤ –¥–∞–Ω–Ω—ã—Ö.
–¢–µ–∑–∏—Å—ã:
1. –ö–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Ä–∞–∑—Ä—ã–≤
–°—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö (PDB) –¥–ª—è –∫–æ–º–ø–ª–µ–∫—Å–æ–≤ –∞–Ω—Ç–∏—Ç–µ–ª–æ‚Äì–∞–Ω—Ç–∏–≥–µ–Ω: ~5‚Äì10 —Ç—ã—Å. —É–Ω–∏–∫–∞–ª—å–Ω—ã—Ö —Å—Ç—Ä—É–∫—Ç—É—Ä
–°–∏–∫–≤–µ–Ω—Å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö (OAS, GenBank, iReceptor): ~1‚Äì2 –º–ª—Ä–¥ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π –∞–Ω—Ç–∏—Ç–µ–ª
–†–∞–∑—Ä—ã–≤: 5‚Äì6 –ø–æ—Ä—è–¥–∫–æ–≤ –≤–µ–ª–∏—á–∏–Ω—ã
–°—Ç—Ä—É–∫—Ç—É—Ä—ã –¥–æ—Ä–æ–≥–∏ –≤ –ø–æ–ª—É—á–µ–Ω–∏–∏ (—Ä–µ–Ω—Ç–≥–µ–Ω, –∫—Ä–∏–æ-–≠–ú), —Å–∏–∫–≤–µ–Ω—Å—ã ‚Äî –¥—ë—à–µ–≤—ã (NGS)
2. –ò–Ω—Ñ–æ—Ä–º–∞—Ç–∏–≤–Ω–æ—Å—Ç—å —Å—Ç—Ä—É–∫—Ç—É—Ä
–°—Ç—Ä—É–∫—Ç—É—Ä—ã –¥–∞—é—Ç –ø—Ä—è–º—É—é –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ –∫–æ–Ω—Ç–∞–∫—Ç–Ω—ã—Ö –æ—Å—Ç–∞—Ç–∫–∞—Ö, –≥–µ–æ–º–µ—Ç—Ä–∏–∏ –∏–Ω—Ç–µ—Ä—Ñ–µ–π—Å–∞
–ù–µ–æ–±—Ö–æ–¥–∏–º—ã –¥–ª—è –ø–æ–Ω–∏–º–∞–Ω–∏—è –º–µ—Ö–∞–Ω–∏–∑–º–∞ —Å–≤—è–∑—ã–≤–∞–Ω–∏—è
–ù–æ: —Å—Ç–∞—Ç–∏—á–Ω—ã, –Ω–µ –æ—Ç—Ä–∞–∂–∞—é—Ç –¥–∏–Ω–∞–º–∏–∫—É –∏ ensemble —Å–æ—Å—Ç–æ—è–Ω–∏–π
3. –ò–Ω—Ñ–æ—Ä–º–∞—Ç–∏–≤–Ω–æ—Å—Ç—å —Å–∏–∫–≤–µ–Ω—Å–æ–≤
–°–∏–∫–≤–µ–Ω—Å—ã –Ω–µ—è–≤–Ω–æ –∫–æ–¥–∏—Ä—É—é—Ç —Å—Ç—Ä—É–∫—Ç—É—Ä—É (sequence ‚Üí structure mapping)
–≠–≤–æ–ª—é—Ü–∏–æ–Ω–Ω—ã–µ –ø–∞—Ç—Ç–µ—Ä–Ω—ã –≤ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—è—Ö –æ—Ç—Ä–∞–∂–∞—é—Ç —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è
LLM –Ω–∞ —Å–∏–∫–≤–µ–Ω—Å–∞—Ö —É—á–∞—Ç latent representations, –∫–æ—Ç–æ—Ä—ã–µ –∫–æ—Ä—Ä–µ–ª–∏—Ä—É—é—Ç —Å–æ —Å—Ç—Ä—É–∫—Ç—É—Ä–æ–π –∏ —Ñ—É–Ω–∫—Ü–∏–µ–π
4. –ü—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ —Å–æ–æ–±—Ä–∞–∂–µ–Ω–∏—è
–í—ã—á–∏—Å–ª–∏—Ç–µ–ª—å–Ω–∞—è —Å–ª–æ–∂–Ω–æ—Å—Ç—å: —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã–µ –º–æ–¥–µ–ª–∏ —Ç—Ä–µ–±—É—é—Ç 3D-–æ–±—Ä–∞–±–æ—Ç–∫–∏ (SE(3)-equivariance, point clouds)
–°–∏–∫–≤–µ–Ω—Å–Ω—ã–µ –º–æ–¥–µ–ª–∏ ‚Äî —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã–µ NLP-–∞—Ä—Ö–∏—Ç–µ–∫—Ç—É—Ä—ã (GPT, BERT)
–ú–∞—Å—à—Ç–∞–±–∏—Ä—É–µ–º–æ—Å—Ç—å: –ª–µ–≥—á–µ –æ–±—É—á–∞—Ç—å –Ω–∞ –±–æ–ª—å—à–∏—Ö –¥–∞–Ω–Ω—ã—Ö
5. –í—ã–≤–æ–¥ –¥–ª—è —Ä–∞–±–æ—Ç—ã
–ü—Ä–∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω—ã—Ö —Ä–µ—Å—É—Ä—Å–∞—Ö —Å–∏–∫–≤–µ–Ω—Å–Ω—ã–π –ø–æ–¥—Ö–æ–¥ –ø–æ–∑–≤–æ–ª—è–µ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –±–æ–ª—å—à–µ –¥–∞–Ω–Ω—ã—Ö
–°—Ç—Ä—É–∫—Ç—É—Ä–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –º–æ–∂–µ—Ç –±—ã—Ç—å –¥–æ–±–∞–≤–ª–µ–Ω–∞ –ø–æ–∑–∂–µ (—á–µ—Ä–µ–∑ –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–µ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã, AF2/3)
‚Üí –û–±–æ—Å–Ω–æ–≤–∞–Ω–∏–µ –≤—ã–±–æ—Ä–∞ sequence-based –º–æ–¥–µ–ª–∏ p-IgGen
3.2 Antigen-specific –±–∞–∑—ã –¥–∞–Ω–Ω—ã—Ö (AgAbDb)
–û—Å–Ω–æ–≤–Ω–∞—è –∏–¥–µ—è —Ä–∞–∑–¥–µ–ª–∞:
–û–ø–∏—Å–∞—Ç—å AgAbDb –∫–∞–∫ –∫–ª—é—á–µ–≤–æ–π –∏—Å—Ç–æ—á–Ω–∏–∫ –¥–∞–Ω–Ω—ã—Ö –∏ –µ–≥–æ –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏.
–¢–µ–∑–∏—Å—ã:
1. –ü—Ä–æ–±–ª–µ–º–∞: –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –±–∞–∑ ‚Äî antigen-agnostic
OAS, GenBank: –º–∏–ª–ª–∏–∞—Ä–¥—ã —Å–∏–∫–≤–µ–Ω—Å–æ–≤ –∞–Ω—Ç–∏—Ç–µ–ª –±–µ–∑ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ–± –∞–Ω—Ç–∏–≥–µ–Ω–µ
SAbDab: ~7–∫ —Å—Ç—Ä—É–∫—Ç—É—Ä –∫–æ–º–ø–ª–µ–∫—Å–æ–≤ (–º–∞–ª–æ –¥–ª—è –æ–±—É—á–µ–Ω–∏—è LLM)
–ù–µ—Ç –º–∞—Å—à—Ç–∞–±–Ω—ã—Ö –¥–∞—Ç–∞—Å–µ—Ç–æ–≤ "–∞–Ω—Ç–∏—Ç–µ–ª–æ + –∞–Ω—Ç–∏–≥–µ–Ω + –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç—å"
2. AgAbDb (NaturalAntibody) –∫–∞–∫ —Ä–µ—à–µ–Ω–∏–µ
–ê–≥—Ä–µ–≥–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –±–∞–∑–∞: ~1.2‚Äì1.5 –º–ª–Ω –∑–∞–ø–∏—Å–µ–π –ø–∞—Ä –∞–Ω—Ç–∏–≥–µ–Ω‚Äì–∞–Ω—Ç–∏—Ç–µ–ª–æ
–ò—Å—Ç–æ—á–Ω–∏–∫–∏: –Ω–∞—É—á–Ω—ã–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏, –ø–∞—Ç–µ–Ω—Ç—ã, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ë–î (CoV-AbDab, HIV-Ab, etc.)
–í–∫–ª—é—á–∞–µ—Ç: –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ VH/VL, –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å/ID –∞–Ω—Ç–∏–≥–µ–Ω–∞, –º–µ—Ç—Ä–∏–∫–∏ –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏
3. –û—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏ –∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è AgAbDb
–ì–µ—Ç–µ—Ä–æ–≥–µ–Ω–Ω–æ—Å—Ç—å –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏: —Ä–∞–∑–Ω—ã–µ —Ç–∏–ø—ã –∏–∑–º–µ—Ä–µ–Ω–∏–π (KD, IC50, ELISA, bool, fuzzy)
Selection bias: –ø—Ä–µ–æ–±–ª–∞–¥–∞–Ω–∏–µ —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏-—Ä–µ–ª–µ–≤–∞–Ω—Ç–Ω—ã—Ö –º–∏—à–µ–Ω–µ–π (–≤–∏—Ä—É—Å–Ω—ã–µ –±–µ–ª–∫–∏, –æ–Ω–∫–æ–º–∞—Ä–∫–µ—Ä—ã)
–ù–µ–ø–æ–ª–Ω–æ—Ç–∞: –Ω–µ –≤—Å–µ –∑–∞–ø–∏—Å–∏ –∏–º–µ—é—Ç –ø–æ–ª–Ω—ã–µ –ø–∞—Ä–Ω—ã–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ VH+VL
–î—É–±–ª–∏—Ä–æ–≤–∞–Ω–∏–µ: –æ–¥–Ω–∏ –∏ —Ç–µ –∂–µ –∞–Ω—Ç–∏—Ç–µ–ª–∞ –º–æ–≥—É—Ç –±—ã—Ç—å –∏–∑ —Ä–∞–∑–Ω—ã—Ö –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤
–°—Ä–µ–¥–Ω—è—è —É–≤–µ—Ä–µ–Ω–Ω–æ—Å—Ç—å –≤ –ø–∞—Ç–µ–Ω—Ç–∞—Ö
4. –°—Ä–∞–≤–Ω–µ–Ω–∏–µ —Å –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–∞–º–∏
–ë–∞–∑–∞	–†–∞–∑–º–µ—Ä	Antigen-aware	–ê—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç—å	–ü–∞—Ä–Ω—ã–µ VH/VL
OAS	~2B	‚ùå	‚ùå	–ß–∞—Å—Ç–∏—á–Ω–æ
SAbDab	~7k	‚úÖ (—Å—Ç—Ä—É–∫—Ç—É—Ä—ã)	–ß–∞—Å—Ç–∏—á–Ω–æ	‚úÖ
AgAbDb	~1.2M	‚úÖ	‚úÖ	–ß–∞—Å—Ç–∏—á–Ω–æ
CoV-AbDab	~13k	‚úÖ	‚úÖ	‚úÖ


5. –ü–æ—á–µ–º—É AgAbDb –¥–ª—è –¥–∞–Ω–Ω–æ–π —Ä–∞–±–æ—Ç—ã
–ï–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –∫—Ä—É–ø–Ω—ã–π –∏—Å—Ç–æ—á–Ω–∏–∫ —Å antigen‚Äìantibody –ø–∞—Ä–∞–º–∏ –∏ –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç—å—é
–î–æ—Å—Ç–∞—Ç–æ—á–Ω—ã–π —Ä–∞–∑–º–µ—Ä –¥–ª—è –¥–æ–æ–±—É—á–µ–Ω–∏—è —è–∑—ã–∫–æ–≤–æ–π –º–æ–¥–µ–ª–∏
–ù–∞–ª–∏—á–∏–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π –∞–Ω—Ç–∏–≥–µ–Ω–æ–≤ (–∞ –Ω–µ —Ç–æ–ª—å–∫–æ ID)

2.1. –°–±–æ—Ä –∏ –Ω–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏—è (–æ–±—â–∞—è —Å—Ö–µ–º–∞)

–ê–≤—Ç–æ—Ä—ã –æ–ø–∏—Å—ã–≤–∞—é—Ç ‚Äúmulti-stage pipeline‚Äù: –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–æ–µ –∏–∑–≤–ª–µ—á–µ–Ω–∏–µ ‚Üí –Ω–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏—è ‚Üí —Ä—É—á–Ω–∞—è –≤–µ—Ä–∏—Ñ–∏–∫–∞—Ü–∏—è. –ò—Å—Ç–æ—á–Ω–∏–∫–∏: —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã–µ –±–∞–∑—ã (PDB), –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ (GenBank), –ª–∏—Ç–µ—Ä–∞—Ç—É—Ä–∞/–ø–∞—Ç–µ–Ω—Ç—ã (–≤ —Ç.—á. —á–µ—Ä–µ–∑ NLP –∏ OCR).

–ö–ª—é—á–µ–≤–æ–π –¥–∏–∑–∞–π–Ω-–ø—Ä–∏–Ω—Ü–∏–ø: –∫–∞–∂–¥—ã–π –∏—Å—Ç–æ—á–Ω–∏–∫ –æ–±—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç—Å—è –æ—Ç–¥–µ–ª—å–Ω–æ —Ç–∞–∫, —á—Ç–æ–±—ã —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å ‚Äú–≥–µ—Ç–µ—Ä–æ–≥–µ–Ω–Ω–æ—Å—Ç—å‚Äù –ø–æ–ª–µ–π (–Ω–∞–ø—Ä–∏–º–µ—Ä, affinity_type, target metadata), —á—Ç–æ–±—ã –ø–æ—Ç–æ–º –º–æ–∂–Ω–æ –±—ã–ª–æ –∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å –∫–∞–∫ –ø–æ –æ—Ç–¥–µ–ª—å–Ω—ã–º –ø–æ–¥-–¥–∞—Ç–∞—Å–µ—Ç–∞–º, —Ç–∞–∫ –∏ –ø–æ –∏—Ö –ª—é–±—ã–º –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏—è–º.

2.2. –í–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–µ–π –∏ ‚Äú–∂—ë—Å—Ç–∫–∏–µ‚Äù —Ñ–∏–ª—å—Ç—Ä—ã –Ω–∞ –∏—Å–∫–ª—é—á–µ–Ω–∏–µ

–¢–∏–ø–æ–≤—ã–µ —Å–∏—Ç—É–∞—Ü–∏–∏ –∏ —Ä–µ—à–µ–Ω–∏—è:

–ï—Å–ª–∏ –∞–Ω—Ç–∏–≥–µ–Ω/–∞–Ω—Ç–∏—Ç–µ–ª–æ –Ω–µ –¥–∞–Ω—ã –∫–∞–∫ sequence, –Ω–æ –µ—Å—Ç—å UniProt/PDB id ‚Üí –∞–≤—Ç–æ—Ä—ã –¥–æ—Ç—è–≥–∏–≤–∞—é—Ç –ø–æ–ª–Ω—É—é –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∏–∑ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–π –ë–î –∏ –¥–æ–±–∞–≤–ª—è—é—Ç ID –≤ –º–µ—Ç–∞–¥–∞–Ω–Ω—ã–µ.

–ï—Å–ª–∏ –µ—Å—Ç—å ‚Äúparental sequence + —Å–ø–∏—Å–æ–∫ –º—É—Ç–∞—Ü–∏–π‚Äù ‚Üí –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å –≤–æ—Å—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—é—Ç –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –º—É—Ç–∞—Ü–∏–π (–≤ —Ä—è–¥–µ —Å–ª—É—á–∞–µ–≤ –≤—Ä—É—á–Ω—É—é).

–ï—Å–ª–∏ –æ–±—Ä–∞–∑–µ—Ü/—Å—Ç–∞—Ç—å—è –Ω–µ —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∏—Ä—É–µ—Ç—Å—è –∏–ª–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ —Å–≤—è–∑—ã–≤–∞–Ω–∏–∏ —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω–∞, –∑–∞–ø–∏—Å—å —É–¥–∞–ª—è–µ—Ç—Å—è (‚Äúremoved from the dataset‚Äù).

–≠—Ç–æ –≤–∞–∂–Ω—ã–π –º–æ–º–µ–Ω—Ç: –≥–ª–∞–≤–Ω—ã–π ‚Äú—Ñ–∏–ª—å—Ç—Ä‚Äù ASD ‚Äî –Ω–µ –≤–∫–ª—é—á–∞—Ç—å —Ç–æ, —á—Ç–æ –Ω–µ–ª—å–∑—è –æ–¥–Ω–æ–∑–Ω–∞—á–Ω–æ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–∏—Ç—å/–∏–¥–µ–Ω—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞—Ç—å.

2.3. OCR/LLM-–∏–∑–≤–ª–µ—á–µ–Ω–∏–µ (–∏ —Ä—É—á–Ω–∞—è –ø—Ä–∞–≤–∫–∞)

–î–ª—è —á–∞—Å—Ç–∏ –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤ —Ç–∞–±–ª–∏—Ü—ã –±—ã–ª–∏ –≤ PDF/–∫–∞—Ä—Ç–∏–Ω–∫–∞—Ö ‚Üí –¥–µ–ª–∞–ª–∏ OCR (—É–ø–æ–º–∏–Ω–∞—é—Ç Claude Opus —á–µ—Ä–µ–∑ web-–∏–Ω—Ç–µ—Ä—Ñ–µ–π—Å) –∏ –∑–∞—Ç–µ–º –≤—Ä—É—á–Ω—É—é –∏—Å–ø—Ä–∞–≤–ª—è–ª–∏ –æ—à–∏–±–∫–∏ OCR.
–ü—Ä–∏–º–µ—Ä: DLGO ‚Äî —Å–Ω–∞—á–∞–ª–∞ Claude Opus –ø–æ–º–æ–≥ ‚Äú—Å–æ–±—Ä–∞—Ç—å‚Äù —Ç–∞–±–ª–∏—Ü—É –≤ CSV, –∑–∞—Ç–µ–º –æ—à–∏–±–∫–∏ OCR –≤—Ä—É—á–Ω—É—é –ø–æ–ø—Ä–∞–≤–∏–ª–∏, –ø–æ—Ç–æ–º –∏–∑ ‚Äúmutation points‚Äù –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–∏–ª–∏ –ø–æ–ª–Ω—ã–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏.

2.4. –ù–∞–∑–Ω–∞—á–µ–Ω–∏–µ –∞–Ω—Ç–∏–≥–µ–Ω–æ–≤, –∫–æ–≥–¥–∞ ‚Äú–µ—Å—Ç—å —Ç–æ–ª—å–∫–æ –∏–º—è‚Äù

–î–ª—è —Ä—è–¥–∞ –Ω–∞–±–æ—Ä–æ–≤ (–Ω–∞–ø—Ä–∏–º–µ—Ä, Flab-–ø–æ–¥–Ω–∞–±–æ—Ä—ã) –±—ã–ª–∏ –ø–æ–ª–Ω—ã–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∞–Ω—Ç–∏—Ç–µ–ª –∏ KD, –Ω–æ –Ω–µ –±—ã–ª–æ sequence –∞–Ω—Ç–∏–≥–µ–Ω–∞. –≠—Ç–æ ‚Äú—Ä–µ–º–µ–¥–∏–ª–∏‚Äù —Ç–µ–º, —á—Ç–æ –Ω–∞–∑–Ω–∞—á–∞–ª–∏ target sequence –ø–æ –∏–º–µ–Ω–∏ –∞–Ω—Ç–∏–≥–µ–Ω–∞ –∏–∑ —Å—Ç–∞—Ç—å–∏, —Å —É—Ä–æ–≤–Ω–µ–º —É–≤–µ—Ä–µ–Ω–Ω–æ—Å—Ç–∏, –∑–∞–≤–∏—Å—è—â–∏–º –æ—Ç –∫–∞—á–µ—Å—Ç–≤–∞ –∏—Å—Ç–æ—á–Ω–∏–∫–∞.

2.5. Confidence tiers (—ç—Ç–æ –∏ –µ—Å—Ç—å –æ—Å–Ω–æ–≤–Ω–æ–π ‚Äú–≤—Å—Ç—Ä–æ–µ–Ω–Ω—ã–π —Ñ–∏–ª—å—Ç—Ä‚Äù)

–£ ASD –µ—Å—Ç—å –∫–∞—Ç–µ–≥–æ—Ä–∏–∞–ª—å–Ω–∞—è –º–µ—Ç–∫–∞ confidence –∏ –∞–≤—Ç–æ—Ä—ã –ø—Ä—è–º–æ –æ–±—ä—è—Å–Ω—è—é—Ç —Å–º—ã—Å–ª –∫–∞—Ç–µ–≥–æ—Ä–∏–π:

medium: –∑–∞–ø–∏—Å–∏, —Å–æ–±—Ä–∞–Ω–Ω—ã–µ –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏/–ø–æ–ª—É–∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏, –≤–∫–ª—é—á–∞—è LLM-–∞–≥–µ–Ω—Ç–æ–≤.

high: ‚Äúwell-structured datasets‚Äù, –Ω–æ —Ç—Ä–µ–±—É—é—â–∏–µ –ø–æ–¥—Ç—è–≥–∏–≤–∞–Ω–∏—è sequence –∏–∑ –≤–Ω–µ—à–Ω–∏—Ö –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤ (PDB/UniProt).

very_high: –µ—Å—Ç—å affinity, affinity type –∏ sequences –∞–Ω—Ç–∏–≥–µ–Ω–æ–≤/–∞–Ω—Ç–∏—Ç–µ–ª –±–µ–∑ —Ä—É—á–Ω—ã—Ö –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤.

–ü–ª—é—Å —Ç–∞–±–ª–∏—Ü–∞ –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤ –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç, —á—Ç–æ patents –ø–æ–º–µ—á–µ–Ω—ã –∫–∞–∫ medium, –∞ structural datasets ‚Äî very_high (–ª–æ–≥–∏–∫–∞: –≤ –ø–∞—Ç–µ–Ω—Ç–∞—Ö –Ω–µ–ª—å–∑—è –±—ã—Ç—å —É–≤–µ—Ä–µ–Ω–Ω—ã–º, —á—Ç–æ –º–æ–ª–µ–∫—É–ª—ã —Ä–µ–∞–ª—å–Ω–æ —Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–ª–∏).

2.6. –ï–¥–∏–Ω–∞—è —Å—Ö–µ–º–∞ –¥–∞–Ω–Ω—ã—Ö (—á—Ç–æ –∏–º–µ–Ω–Ω–æ –º–æ–∂–Ω–æ —Ñ–∏–ª—å—Ç—Ä–æ–≤–∞—Ç—å)

–û–Ω–∏ –ø—Ä–∏–≤–æ–¥—è—Ç —Å—Ö–µ–º—É (Table 3): dataset, heavy_sequence, light_sequence, antigen_sequence, affinity_type, affinity, –º–µ—Ç–∞–¥–∞–Ω–Ω—ã–µ (target_uniprot, target_pdb, target_name, source_url‚Ä¶), confidence, —Ñ–ª–∞–≥ scfv, –ø–ª—é—Å —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –Ω—É–º–µ—Ä–∞—Ü–∏–∏ RIOT –ø–æ —Ü–µ–ø—è–º


6. –ü–æ–¥–≥–æ—Ç–æ–≤–∫–∞ –¥–∞–Ω–Ω—ã—Ö (–ø–µ—Ä–µ—Ö–æ–¥ –∫ 3.3)
–ù–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å —É–Ω–∏—Ñ–∏–∫–∞—Ü–∏–∏ —Ä–∞–∑–Ω–æ—Ä–æ–¥–Ω—ã—Ö –º–µ—Ç—Ä–∏–∫ ‚Üí –±–∏–Ω–∞—Ä–∏–∑–∞—Ü–∏—è
–§–∏–ª—å—Ç—Ä–∞—Ü–∏—è –ø–æ –∫–∞—á–µ—Å—Ç–≤—É (–ø–æ–ª–Ω—ã–µ –ø–∞—Ä—ã, –∏–∑–≤–µ—Å—Ç–Ω—ã–π –∞–Ω—Ç–∏–≥–µ–Ω)

  3.3 –ë–∏–Ω–∞—Ä–∏–∑–∞—Ü–∏—è –∞—Ñ—Ñ–∏–Ω–∏—Ç–µ—Ç–∞
–≤–æ—Ç —ç—Ç–æ—Ç —Ä–∞–∑–¥–µ–ª –ø–æ–∫–∞ –Ω–µ –ø–∏—Å–∞—Ç—å, —è –ø–æ—Ç–æ–º –æ—Ç–¥–µ–ª—å–Ω–æ —Å–¥–µ–ª–∞—é
4. –ú–æ–¥–µ–ª–∏
  4.1 –°—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã–µ –∏ –≥–∏–±—Ä–∏–¥–Ω—ã–µ (RFantibody, DiffAb)
  4.2 –°–∏–∫–≤–µ–Ω—Å–Ω—ã–µ –∏ LLM
  4.3 p-IgGen –∫–∞–∫ –≤—ã–±–æ—Ä
–ü–æ—á–µ–º—É –æ–Ω –ª—É—á—à–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è–º —Ä–∞–∑–¥–µ–ª–∞ 2
5. –û–±—É—á–µ–Ω–∏–µ / –ê–¥–∞–ø—Ç–∞—Ü–∏—è –º–æ–¥–µ–ª–µ–π *–æ–ø–∏—à–µ–º –ø–æ—Å–ª–µ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞
  5.1 Fine-tuning –∏ PEFT
–£–ø–æ–º—è–Ω—É—Ç—å –ø—Ä–æ –ö–∞—Ç–∞—Å—Ç—Ä–æ—Ñ–∏—á–µ—Å–∫–æ–µ –∑–∞–±—ã–≤–∞–Ω–∏–µ





# –õ–∏—Ç–æ–±–∑–æ—Ä
#### –ê–∫—Ç—É–∞–ª—å–Ω–æ—Å—Ç—å 
<!-- AGENT_INSTRUCTION: –ù–∞–ø–∏—à–∏ —ç—Ç—É —á–∞—Å—Ç—å –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–ª–µ–¥—É—é—â–∏—Ö —Ä–∞–∑–¥–µ–ª–æ–≤ -->

#### –ê–Ω—Ç–∏—Ç–µ–ª–æ-–∞–Ω—Ç–∏–≥–µ–Ω –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è –∫–∞–∫ –æ–±—ä–µ–∫—Ç –º–æ–¥–µ–ª–∏—Ä–æ–≤–∞–Ω–∏—è
https://chatgpt.com/share/6960542c-57d4-8008-afa9-52a8dfd3470c

#### –î–∞–Ω–Ω—ã–µ


#### –ë–∏–Ω–∞—Ä–∏–∑–∞—Ü–∏—è –∞—Ñ—Ñ–∏–Ω–Ω—Ç–µ—Ç–∞

–°–≤—è–∑—å –º–µ–∂–¥—É –Ω–µ–∫–æ—Ç–æ—Ä—ã–º–∏ —Ç–∏–ø–∞–º–∏ –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç–∏ –∏ –ö–î –æ—á–µ–Ω—å —Å–ª–æ–∂–Ω–∞ –∏ —Å–∏–ª—å–Ω–æ –∑–∞–≤–∏—Å–∏—Ç –æ—Ç –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã—Ö —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω—ã—Ö —É—Å–ª–æ–≤–∏–π, –ø–æ—ç—Ç–æ–º—É –Ω–∞–ø—Ä—è–º—É—é –ø—Ä–µ–æ–±—Ä–∞–∑–æ–≤–∞—Ç—å –∏—Ö –∑–Ω–∞—á–µ–Ω–∏–µ –≤ –∫–æ–Ω—Å—Ç–∞–Ω—Ç—É –¥–∏—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ. –ù–æ –º—ã –ø–æ–ø—Ä–æ–±–æ–≤–∞–ª–∏ –≤–∑—è—Ç—å –ø–æ—Ä–æ–≥–∏ –ø—Ä–∏–º–µ—Ä–Ω–æ —Å—Ä–∞–≤–Ω–∏–º—ã–µ —Å –ö–î = 100–Ω–ú

affinity_type
fuzzy                    524346
bool                     336761
alphaseq                 198703
-log KD                  152401
kd                         7007
log_enrichment             3452
delta_g                    2725
ddg                         670
elisa_mut_to_wt_ratio       658
ic_50                       360

##### fuzzy
h

##### bool
–ø–æ-—Ä–∞–∑–Ω–æ–º—É


##### alphaseq


##### KD –∏ -log(KD)


##### log_enrichment
`Log_enrichment` –æ—Ç—Ä–∞–∂–∞–µ—Ç, –Ω–∞—Å–∫–æ–ª—å–∫–æ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –¥–æ–ª—è –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ–≥–æ –≤–∞—Ä–∏–∞–Ω—Ç–∞ –∞–Ω—Ç–∏—Ç–µ–ª–∞ –ø–æ—Å–ª–µ —Ä–∞—É–Ω–¥–∞ –æ—Ç–±–æ—Ä–∞, –∏ –Ω–∞ —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –≤–ª–∏—è—é—Ç –Ω–µ —Ç–æ–ª—å–∫–æ –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç—å —Å–≤—è–∑—ã–≤–∞–Ω–∏—è (–ö–î), –Ω–æ –∏ –¥—Ä—É–≥–∏–µ —Ñ–∞–∫—Ç–æ—Ä—ã, —Ç–∞–∫–∏–µ –∫–∞–∫ —É—Ä–æ–≤–µ–Ω—å —ç–∫—Å–ø—Ä–µ—Å—Å–∏–∏ –±–µ–ª–∫–∞, –µ–≥–æ —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç—å –∏ —Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–∏–µ –ø–∞—Ä–∞–º–µ—Ç—Ä—ã –ø—Ä–æ—Ç–æ–∫–æ–ª–∞ –æ—Ç–±–æ—Ä–∞ (–∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏—è –∞–Ω—Ç–∏–≥–µ–Ω–∞, –∂–µ—Å—Ç–∫–æ—Å—Ç—å –ø—Ä–æ–º—ã–≤–∫–∏ –∏ —Ç.–¥.).

log10‚Äã(KD[nM]‚Äã)‚âàa‚àíb√ólog_enrichment.

| –ò—Å—Ç–æ—á–Ω–∏–∫                                                | –£—Å–ª–æ–≤–∏–µ                                     | a         | b     | –ü—Ä–∏–º–µ—á–∞–Ω–∏–µ                           |
| ------------------------------------------------------- | ------------------------------------------- | --------- | ----- | ------------------------------------ |
| *Adams et al., 2016, Cell Systems*                      | Yeast display, binding to antigen           | ‚âà 3.0     | ‚âà 0.9 | log_enrichment=0 ‚Üí KD‚âà1 ŒºM           |
| *Whitehead et al., 2012, Nat Biotech*                   | Phage display, antibody affinity maturation | ‚âà 2.5‚Äì3.0 | ‚âà 1.0 | Œîlog_enrichment=1 ‚Üí √ó10 —É–ª—É—á—à–µ–Ω–∏–µ KD |
| *Fowler et al., 2010, Nature Methods (DMS Œ≤-lactamase)* | Enzyme activity proxy                       | ‚âà 3.5     | ‚âà 0.7 | –ú–µ–Ω–µ–µ –ø—Ä—è–º–∞—è —Å–≤—è–∑—å                   |
| *Bloom Lab datasets (RBD DMS, 2020‚Äì2022)*               | SARS-CoV-2 RBD binding to ACE2              | ‚âà 2.7     | ‚âà 0.8 | –®–∏—Ä–æ–∫–æ –ø—Ä–∏–º–µ–Ω—è–µ–º–∞—è –∞–ø–ø—Ä–æ–∫—Å–∏–º–∞—Ü–∏—è     |

–¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, —É–Ω–∏–≤–µ—Ä—Å–∞–ª—å–Ω–∞—è –∞–ø–ø—Ä–æ–∫—Å–∏–º–∞—Ü–∏—è (–µ—Å–ª–∏ —É —Ç–µ–±—è –Ω–µ—Ç —Å–≤–æ–∏—Ö –∫–∞–ª–∏–±—Ä–æ–≤–æ—á–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö) –º–æ–∂–µ—Ç –±—ã—Ç—å:
log10(KD[nM])=3.0‚àí1.0√ólog_enrichment
	‚Äã
–¢–æ–≥–¥–∞:

| KD (–Ω–ú)         | log‚ÇÅ‚ÇÄ(KD) | –ü—Ä–∏–º–µ—Ä–Ω—ã–π log_enrichment |
| --------------- | --------- | ------------------------ |
| 10‚Å¥ nM (10 ŒºM)  | 4         | ‚âà ‚àí1                     |
| 10¬≥ nM (1 ŒºM)   | 3         | ‚âà 0                      |
| 10¬≤ nM (100 nM) | 2         | ‚âà +1                     |
| 10 nM           | 1         | ‚âà +2                     |
| 1 nM            | 0         | ‚âà +3                     |

–í—ã–±–∏—Ä–∞–µ–º –ø–æ—Ä–æ–≥ +1
–ü—Ä–æ–≤–∞–ª–∏–¥–∏—Ä–æ–≤–∞–ª–∏ –ø–æ—Ä–æ–≥–∏ –Ω–∞ –¥–∞–Ω–Ω—ã—Ö ‚Äî –Ω–∞ —Å–ª—É—á–∞—è—Ö, –∫–æ–≥–¥–∞ –¥–ª—è –∫–æ–º–ø–ª–µ–∫—Å–∞ –µ—Å—Ç—å –∏–∑–º–µ—Ä–µ–Ω–∏–µ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Ç–∏–ø–æ–≤ –∞—Ñ—Ñ–∏–Ω–æ—Å—Ç–∏
...

##### delta_g

–ò—Å–ø–æ–ª—å–∑—É—è —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–µ —É—Ä–∞–≤–Ω–µ–Ω–∏–µ:

ŒîG=RTln‚Å°(KD)
–ø—Ä–∏ T=298K:
ŒîG(100nM)‚âà‚àí9.54¬†kcal/mol

–¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, **–ø–æ—Ä–æ–≥ ŒîG ‚âà ‚àí9.5 kcal/mol** —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç **KD = 100 nM**, –∏ —Å–æ–≤–ø–∞–¥–∞–µ—Ç —Å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–º –ø–æ—Ä–æ–≥–æ–º, –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–Ω—ã–º –≤ NaturalAntibody –¥–ª—è –∞–Ω–Ω–æ—Ç–∞—Ü–∏–∏ ¬´binding¬ª.

##### ddg
—Ç—É—Ç –≤—ã–∫–∏–Ω–µ–º –≤–∏–¥–∏–º–æ


##### elisa_mut_to_wt_ratio
–æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–æ—Å—Ç–∏ ELISA-—Å–∏–≥–Ω–∞–ª–∞ –º—É—Ç–∞–Ω—Ç–∞ –∫ –¥–∏–∫–æ–º—É —Ç–∏–ø—É (WT) –ø—Ä–∏ —Å–≤—è–∑—ã–≤–∞–Ω–∏–∏ —Å —Ç–µ–º –∂–µ –∞–Ω—Ç–∏–≥–µ–Ω–æ–º.
ELISA ratio = SignalWT / Signalmut

üìä –≠–º–ø–∏—Ä–∏—á–µ—Å–∫–∞—è –∫–∞–ª–∏–±—Ä–æ–≤–∫–∞ (—Ç–∏–ø–∏—á–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ)
| KD (–º—É—Ç–∞–Ω—Ç) | KD/WT | ELISA ratio (–º—É—Ç/WT) | –ò–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∞—Ü–∏—è            |
| ----------- | ----- | -------------------- | ------------------------ |
| 10 nM       | 0.1√ó  | ‚âà 1.8‚Äì2.0            | –û—á–µ–Ω—å –≤—ã—Å–æ–∫–∞—è –∞—Ñ—Ñ–∏–Ω–Ω–æ—Å—Ç—å |
| 100 nM      | 1√ó    | ‚âà 1.0                | –°—Ä–µ–¥–Ω—è—è (—Ä–µ—Ñ–µ—Ä–µ–Ω—Å WT)    |
| 1 ¬µM        | 10√ó   | ‚âà 0.5                | –°—Ä–µ–¥–Ω—è—è/–Ω–∏–∑–∫–∞—è           |
| 10 ¬µM       | 100√ó  | ‚âà 0.2‚Äì0.3            | –°–ª–∞–±–æ–µ —Å–≤—è–∑—ã–≤–∞–Ω–∏–µ        |


(–ü–æ—Å—Ç—Ä–æ–µ–Ω–æ –Ω–∞ –¥–∞–Ω–Ω—ã—Ö –∏–∑ Carter et al., Methods Enzymol., 1994
 –∏ –ø–æ—Å–ª–µ–¥—É—é—â–∏—Ö –∫–∞–ª–∏–±—Ä–æ–≤–æ–∫ ELISA vs KD)

##### ic_50


